Literature DB >> 20071161

Circulating tumor cells: a window into cancer biology and metastasis.

Shyamala Maheswaran1, Daniel A Haber.   

Abstract

The presence of circulating tumor cells (CTCs) accompanies tumor invasion into the bloodstream. Detection, monitoring, and molecular analysis of these rare cancer cells shed into blood will provide a powerful and noninvasive approach for the detection of early disease, assessing prognosis and therapeutic response in established cancers, and targeting metastatic precursor cells. We review current and emerging technologies for CTC isolation, with a focus on capture efficiency, purity, and viability of CTCs, and their potential clinical applications. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071161      PMCID: PMC2846729          DOI: 10.1016/j.gde.2009.12.002

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  17 in total

1.  Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.

Authors:  Daniel C Danila; Glenn Heller; Gretchen A Gignac; Rita Gonzalez-Espinoza; Aseem Anand; Erika Tanaka; Hans Lilja; Lawrence Schwartz; Steven Larson; Martin Fleisher; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

Review 2.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

3.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Authors:  Massimo Cristofanilli; Daniel F Hayes; G Thomas Budd; Mathew J Ellis; Alison Stopeck; James M Reuben; Gerald V Doyle; Jeri Matera; W Jeffrey Allard; M Craig Miller; Herbert A Fritsche; Gabriel N Hortobagyi; Leon W M M Terstappen
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

4.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

5.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

6.  Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Authors:  Sunitha Nagrath; Lecia V Sequist; Shyamala Maheswaran; Daphne W Bell; Daniel Irimia; Lindsey Ulkus; Matthew R Smith; Eunice L Kwak; Subba Digumarthy; Alona Muzikansky; Paula Ryan; Ulysses J Balis; Ronald G Tompkins; Daniel A Haber; Mehmet Toner
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

7.  [Detection and quantification of circulating tumor cells in peripheral blood in patients with colon cancer].

Authors:  Marta Vidaurreta; Javier Sastre; María Teresa Sanz-Casla; María Luisa Maestro; Sara Rafael; Eduardo Díaz-Rubio
Journal:  Med Clin (Barc)       Date:  2007-09-15       Impact factor: 1.725

8.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.

Authors:  Siyang Zheng; Henry Lin; Jing-Quan Liu; Marija Balic; Ram Datar; Richard J Cote; Yu-Chong Tai
Journal:  J Chromatogr A       Date:  2007-05-29       Impact factor: 4.759

9.  High speed detection of circulating tumor cells.

Authors:  H Ben Hsieh; Dena Marrinucci; Kelly Bethel; Douglas N Curry; Mark Humphrey; Robert T Krivacic; Joan Kroener; Lindsay Kroener; Andras Ladanyi; Nicole Lazarus; Peter Kuhn; Richard H Bruce; Jorge Nieva
Journal:  Biosens Bioelectron       Date:  2006-02-07       Impact factor: 10.618

10.  Detection of mutations in EGFR in circulating lung-cancer cells.

Authors:  Shyamala Maheswaran; Lecia V Sequist; Sunitha Nagrath; Lindsey Ulkus; Brian Brannigan; Chey V Collura; Elizabeth Inserra; Sven Diederichs; A John Iafrate; Daphne W Bell; Subba Digumarthy; Alona Muzikansky; Daniel Irimia; Jeffrey Settleman; Ronald G Tompkins; Thomas J Lynch; Mehmet Toner; Daniel A Haber
Journal:  N Engl J Med       Date:  2008-07-02       Impact factor: 91.245

View more
  129 in total

1.  Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.

Authors:  Steven M Santana; He Liu; Neil H Bander; Jason P Gleghorn; Brian J Kirby
Journal:  Biomed Microdevices       Date:  2012-04       Impact factor: 2.838

2.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

3.  Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Nanomater       Date:  2012       Impact factor: 2.986

4.  Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo.

Authors:  Shreyas S Rao; Grace G Bushnell; Samira M Azarin; Graham Spicer; Brian A Aguado; Jenna R Stoehr; Eric J Jiang; Vadim Backman; Lonnie D Shea; Jacqueline S Jeruss
Journal:  Cancer Res       Date:  2016-09-15       Impact factor: 12.701

5.  Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  Biomaterials       Date:  2015-04-17       Impact factor: 12.479

6.  An automated high-throughput counting method for screening circulating tumor cells in peripheral blood.

Authors:  Mengxia Zhao; Perry G Schiro; Jason S Kuo; Karen M Koehler; Daniel E Sabath; Viorica Popov; Qinghua Feng; Daniel T Chiu
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

Review 7.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

8.  Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Biomed Mater Res A       Date:  2015-03-30       Impact factor: 4.396

Review 9.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

Review 10.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

Authors:  Daniel A Haber; Victor E Velculescu
Journal:  Cancer Discov       Date:  2014-05-06       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.